By: IPP Bureau
Last updated : April 22, 2026 5:32 pm
C-CAMP–Imperial College London partnership to boost biotech research, startup exchange, and translational innovation through a five-year collaboration
The Centre for Cellular and Molecular Platforms (C-CAMP) has entered into a strategic partnership with Imperial College London to establish the Indo-UK Life Sciences Innovation Corridor, a cross-border initiative aimed at strengthening collaboration in biological research and entrepreneurship.
The agreement, formalised through a memorandum of understanding (MoU), seeks to leverage the complementary strengths of both ecosystems by fostering long-term cooperation across research, innovation, and startup development.
The Corridor is envisioned as a platform to enable structured exchange of researchers, innovators, and startups, while also facilitating a two-way flow of knowledge, evidence, and best practices in priority areas of life sciences.
Announced at the C-CAMP campus in Bengaluru, the partnership was signed by Professor Hugh Brady, President, Imperial College London and Dr Taslimarif Saiyed, Director-CEO, C-CAMP.
Prof. Brady described the initiative as a significant step in deepening ties with India’s life sciences ecosystem, noting that it would connect world-class research with entrepreneurship and accelerate the translation of innovations to address global challenges.
Dr. Saiyed highlighted the strategic importance of the five-year collaboration, positioning it as a platform to harness synergies between Bengaluru and London, two major global hubs for biotechnology and innovation.
A key feature of the Corridor will be a bi-directional exchange mechanism, allowing UK-based teams to assess deployment readiness in India, while Indian innovators explore pathways for implementation in the UK and potentially wider European markets.
The initiative will also explore joint fundraising opportunities and partnerships to ensure long-term sustainability and scalability.